We are live on ! Find out more
MLL

Moody Lynn & Lieberson Portfolio holdings

AUM $1.9B
1-Year Est. Return 27.82%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$1.09B
AUM Growth
+$56.4M
Cap. Flow
-$22.7M
Cap. Flow %
-2.08%
Top 10 Hldgs %
29.69%
Holding
244
New
28
Increased
44
Reduced
85
Closed
29

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$15.1M
2
UBER icon
Uber
UBER
+$14M
3
LHX icon
L3Harris
LHX
+$13.9M
4
NEE icon
NextEra Energy
NEE
+$6.74M
5
TMO icon
Thermo Fisher Scientific
TMO
+$6.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.74%
2 Technology 18.18%
3 Financials 16.36%
4 Industrials 11.1%
5 Consumer Staples 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRB icon
51
W.R. Berkley
WRB
$26.6B
$4.67M 0.43%
96,582
+694
+0.7% +$33.5K
A icon
52
Agilent Technologies
A
$41.2B
$4.64M 0.42%
31,008
-175
-0.6% -$25K
GOOG icon
53
Alphabet (Google) Class C
GOOG
$4.32T
$4.58M 0.42%
51,641
-769
-1% -$73.4K
GILD icon
54
Gilead Sciences
GILD
$165B
$4.57M 0.42%
53,286
+48,395
+989% +$3.83M
GPC icon
55
Genuine Parts
GPC
$18.7B
$4.55M 0.42%
26,257
-30
-0.1% -$5.22K
GD icon
56
General Dynamics
GD
$106B
$4.54M 0.42%
18,289
+380
+2% +$92.7K
ADM icon
57
Archer Daniels Midland
ADM
$36.9B
$4.5M 0.41%
+48,485
New +$4.48M
ADP icon
58
Automatic Data Processing
ADP
$108B
$4.47M 0.41%
18,700
-90
-0.5% -$22.1K
AIG icon
59
American International
AIG
$41.3B
$4.39M 0.4%
+69,366
New +$4.04M
NBIX icon
60
Neurocrine Biosciences
NBIX
$16.6B
$4.14M 0.38%
34,645
-35
-0.1% -$4.1K
DD icon
61
DuPont de Nemours
DD
$19.2B
$3.9M 0.36%
+45,305
New +$3.62M
FMC icon
62
FMC
FMC
$1.33B
$3.84M 0.35%
+30,775
New +$3.77M
ROP icon
63
Roper Technologies
ROP
$39.8B
$3.51M 0.32%
+8,132
New +$3.35M
AMGN icon
64
Amgen
AMGN
$222B
$3.51M 0.32%
13,354
+11,675
+695% +$3.13M
XOM icon
65
ExxonMobil
XOM
$634B
$3.45M 0.32%
31,306
+455
+1% +$48.8K
MDLZ icon
66
Mondelez International
MDLZ
$79.9B
$3.44M 0.31%
51,574
+866
+2% +$54.8K
VTI icon
67
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$3.37M 0.31%
17,637
+2,460
+16% +$474K
IDXX icon
68
Idexx Laboratories
IDXX
$46.2B
$3.27M 0.3%
8,023
-101
-1% -$39.2K
LDOS icon
69
Leidos
LDOS
$17.3B
$3.11M 0.28%
+29,530
New +$3.02M
REGN icon
70
Regeneron Pharmaceuticals
REGN
$80.8B
$3.08M 0.28%
4,269
-5
-0.1% -$3.69K
PARA
71
DELISTED
Paramount Global Class B
PARA
$3.06M 0.28%
+181,520
New +$3.34M
BAH icon
72
Booz Allen Hamilton
BAH
$9.15B
$2.92M 0.27%
+27,940
New +$2.9M
GDX icon
73
VanEck Gold Miners ETF
GDX
$27.4B
$2.59M 0.24%
+90,400
New +$2.42M
BG icon
74
Bunge Global
BG
$20.8B
$2.59M 0.24%
+25,925
New +$2.49M
ORCL icon
75
Oracle
ORCL
$423B
$2.56M 0.23%
31,307
+22,061
+239% +$1.68M

Similar funds

Moody Lynn & Lieberson's Q4 2022 Portfolio in Review

As of Q4 2022, Moody Lynn & Lieberson held 244 positions worth $1.09B, up 5.4% from $1.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Moody Lynn & Lieberson's Q4 2022 filing shows 28 new, 44 increased, 85 reduced and 29 closed positions. Its largest new stake was Chevron: 98,175 shares worth $17.6M. The largest sale was Atlassian, an estimated $15.1M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

  • Moody Lynn & Lieberson's largest Q4 2022 buy was Chevron: 98,175 shares worth $17.6M.
  • Moody Lynn & Lieberson added most to Berkshire Hathaway Class B in Q4 2022, an estimated $12.6M increase.
  • Moody Lynn & Lieberson's biggest Q4 2022 reduction was NextEra Energy, cutting an estimated $6.74M.
  • Moody Lynn & Lieberson fully exited Atlassian in Q4 2022, selling an estimated $15.1M.
  • Moody Lynn & Lieberson's ten largest holdings make up 30% of its $1.09B portfolio in Q4 2022.
  • Moody Lynn & Lieberson opened 28 new positions and closed 29 in Q4 2022.
  • Moody Lynn & Lieberson's portfolio value rose 5.4% quarter-over-quarter to $1.09B.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2022, filed 1 Feb 2023.